| Literature DB >> 28262469 |
Adele D'Amico1, Michela Catteruccia2, Giovanni Baranello3, Luisa Politano4, Alessandra Govoni5, Stefano Carlo Previtali6, Marika Pane7, Maria Grazia D'Angelo8, Claudio Bruno9, Sonia Messina10, Federica Ricci11, Elena Pegoraro12, Antonella Pini13, Angela Berardinelli14, Ksenjia Gorni15, Roberta Battini16, Gianluca Vita10, Federica Trucco9, Marianna Scutifero4, Roberta Petillo4, Paola D'Ambrosio4, Anna Ardissone3, Barbara Pasanisi3, Giuseppe Vita10, Tiziana Mongini11, Maurizio Moggio5, Giacomo Pietro Comi5, Eugenio Mercuri7, Enrico Bertini2.
Abstract
Despite all the advances in diagnosis and management of Duchenne muscular dystrophy over the past 50 years, the average age at diagnosis in most countries in the world around is still around 4-5 years. This retrospective study investigates the age at diagnosis in Italy in the past 10 years. We report findings from 384 boys who were diagnosed with DMD from 2005 to 2014. The mean age at first medical contact, which raised the suspicion of DMD, was 31 months. The mean age at diagnosis was 41 months. The finding that more frequently brought to suspect a DMD was the incidental finding of consistent elevated creatine kinase serum level detected during routine assessments in children undergoing general anesthesia or with intercurrent illness. This was followed by motor delay and signs of muscle weakness. Initial concerns were raised by general pediatricians (29%), specialists at tertiary centers (35%) or first level hospitals (23%). In children presenting incidental elevated creatine kinase values the diagnosis was achieved earlier than in children presenting a developmental delay. The mean age at diagnosis in our cohort was about 10-12 months lower than that reported in other countries.Entities:
Keywords: DMD; DMD screening; Delayed diagnosis; Survey
Mesh:
Substances:
Year: 2017 PMID: 28262469 DOI: 10.1016/j.nmd.2017.02.006
Source DB: PubMed Journal: Neuromuscul Disord ISSN: 0960-8966 Impact factor: 4.296